Meissner Rde, V., Barbosa, R.N., Fernandes, J.V., Galvao, T.M., Galvao, A.F. and Oliveira, G.H. (2007) No Association between SNP309 Promoter Polymorphism in the MDM2 and Cervical Cancer in a Study from Northeastern Brazil. Cancer Detection and Prevention, 31, 371-374.
http://dx.doi.org/10.1016/j.cdp.2007.09.001

has been cited by the following article:

• TITLE: MDM2 SNP309 (rs2279744) and p53 Codon Arg72Pro (rs1042522) SNP in Cervical Carcinogenesis

  AUTHORS: Osamu Nunobiki, Hirohide Sawada, Masatsugu Ueda

  KEYWORDS: p53, MDM2, Polymorphism, HPV, Cervical Carcinogenesis

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.5 No.7, June 20, 2014

  ABSTRACT: To investigate the association between polymorphisms (SNP) in the p53 and murine double minute 2 homolog (MDM2) promoter 309 in cervical carcinogenesis. SNP at p53 codon 72 polymorphisms and MDM2 promoter 309 (T/G) together with human papillomavirus (HPV) types were examined in a total of 187 cervical smear samples using real time PCR. 27 cases with HPV types 16 and/or 18 had significantly higher frequency of the TG + GG genotype and G allele than 56 with other types of high-risk HPV (P = 0.0136). 48 cases with HPV types 52 and/or 58 had significantly higher frequency of the TG + GG genotype and G allele than 56 with other types of high-risk HPV (P = 0.001). Our studies have demonstrated that the frequency of G allele in MDM2 promoter 309 increased from LSIL to HSIL and that there was an increased OR for G allele in HSIL cases with high-risk HPV types including 52 and 58. It is known that geographically different oncogenic HPV types 52 and 58 are more prevalent than 16 and 18 in a Japanese population.